Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP405204.RA0DpTv-J-t1fzPNM5i_xgzAXp0cURmuIzaQ9-4nHdVGA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP405204.RA0DpTv-J-t1fzPNM5i_xgzAXp0cURmuIzaQ9-4nHdVGA130_assertion type Assertion NP405204.RA0DpTv-J-t1fzPNM5i_xgzAXp0cURmuIzaQ9-4nHdVGA130_head.
- NP405204.RA0DpTv-J-t1fzPNM5i_xgzAXp0cURmuIzaQ9-4nHdVGA130_assertion wasGeneratedBy ECO_0000203 NP405204.RA0DpTv-J-t1fzPNM5i_xgzAXp0cURmuIzaQ9-4nHdVGA130_provenance.
- NP405204.RA0DpTv-J-t1fzPNM5i_xgzAXp0cURmuIzaQ9-4nHdVGA130_assertion wasDerivedFrom befree-20140225 NP405204.RA0DpTv-J-t1fzPNM5i_xgzAXp0cURmuIzaQ9-4nHdVGA130_provenance.
- NP405204.RA0DpTv-J-t1fzPNM5i_xgzAXp0cURmuIzaQ9-4nHdVGA130_assertion SIO_000772 17854396 NP405204.RA0DpTv-J-t1fzPNM5i_xgzAXp0cURmuIzaQ9-4nHdVGA130_provenance.
- NP405204.RA0DpTv-J-t1fzPNM5i_xgzAXp0cURmuIzaQ9-4nHdVGA130_assertion evidence source_evidence_literature NP405204.RA0DpTv-J-t1fzPNM5i_xgzAXp0cURmuIzaQ9-4nHdVGA130_provenance.
- NP405204.RA0DpTv-J-t1fzPNM5i_xgzAXp0cURmuIzaQ9-4nHdVGA130_assertion description "[Forty-eight cancer tissues were divided into three groups: Group 1, 28 primary cancers; Group 2, 7 recurrences capable of trapping (131)I; and Group 3, 13 recurrences incapable of trapping (131)I. mRNA levels of thyroid genes (sodium/iodide symporter NIS, thyroglobulin, thyroperoxidase and pendrin) and glycolytic metabolism genes (GLUT-1, hexokinase I and II) and BRAF mutations were evaluated in the different groups.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP405204.RA0DpTv-J-t1fzPNM5i_xgzAXp0cURmuIzaQ9-4nHdVGA130_provenance.